Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BrainsWay Ltd.
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
0
0
0
No Price
Closing Price XTAE 01.05.2026:
4.978,00 ILA
01.05.2026 10:48
Current Prices from BrainsWay Ltd.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
TASE
BWAY.TA
ILA
01.05.2026 10:48
4.978,00 ILA
126,00 ILA
+2,60 %
UTC
BRSYF
USD
30.04.2026 20:00
13,55 USD
0,00 USD
Share Float & Liquidity
Free Float82,78 %
Shares Float33,14 M
Shares Outstanding40,03 M
Company Profile for BrainsWay Ltd. Share
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
